In combination protocols, GHK-Cu is typically administered via subcutaneous injection at doses of 200 to 600 mcg daily
In a solution containing sugar, B12 was degraded by about 30%, and in a solution containing iron, B12 was reduced by about 20%
Each vial should clearly indicate peptide name and concentration after reconstitution, reconstitution date, volume of bacteriostatic water added, and dose per unit volume for easy calculation
Therefore, the purpose of this scoping review is to characterize the current evidence base for peptide therapies relevant to musculoskeletal care, with emphasis on BPC-157, thymosin beta-4 derivatives, and related agents, and to define safety considerations and perioperative implications for orthopaedic surgical patients, including those undergoing TJA